Benitec Biopharma (BNTC)
(Delayed Data from NSDQ)
$11.53 USD
-0.10 (-0.82%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $11.59 +0.07 (0.56%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BNTC 11.53 -0.10(-0.82%)
Will BNTC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BNTC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BNTC
Is Cintas (CTAS) Stock Outpacing Its Business Services Peers This Year?
Are Basic Materials Stocks Lagging Harmony Gold (HMY) This Year?
BNTC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Ardagh Metal Packaging (AMBP) Stock Outpacing Its Industrial Products Peers This Year?
Is Root (ROOT) Stock Outpacing Its Finance Peers This Year?
Are Utilities Stocks Lagging CenterPoint Energy (CNP) This Year?
Other News for BNTC
Franklin Biotechnology Discovery Fund Q2 2025 Commentary
Benitec Biopharma management to meet virtually with Piper Sandler
BNTC: Upcoming Virtual Meeting by Piper Sandler | BNTC Stock News
Benitec Biopharma management to meet virtually with Piper Sandler
Benitec Biopharma (BNTC) Moves Forward with Clinical Study Enrollment | BNTC Stock News